Mark S. Drinker

1.6k total citations
5 papers, 847 citations indexed

About

Mark S. Drinker is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Mark S. Drinker has authored 5 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Genetics. Recurrent topics in Mark S. Drinker's work include Virus-based gene therapy research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Mark S. Drinker is often cited by papers focused on Virus-based gene therapy research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Mark S. Drinker collaborates with scholars based in United States. Mark S. Drinker's co-authors include S.D. Weeks, Tauseef R. Butt, Oxana A. Malakhova, Michael P. Malakhov, Michael R. Mattern, Patrick J. Loll, James M. Wilson, Hildegund C.J. Ertl, Guangping Gao and Jeffrey M. Bergelson and has published in prestigious journals such as Journal of Virology, Protein Expression and Purification and Journal of Structural and Functional Genomics.

In The Last Decade

Mark S. Drinker

5 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Drinker United States	5	529	189	180	169	138	5	847
Naoko Miyano‐Kurosaki Japan	16	696 1.3×	176 0.9×	282 1.6×	157 0.9×	40 0.3×	69	1.0k
Michael Dolan United States	22	673 1.3×	93 0.5×	274 1.5×	175 1.0×	86 0.6×	52	1.3k
Royce A. Wilkinson United States	17	521 1.0×	84 0.4×	196 1.1×	74 0.4×	141 1.0×	31	1.2k
Martine Duonor-Cérutti France	18	341 0.6×	81 0.4×	146 0.8×	64 0.4×	82 0.6×	32	674
Susan Thrane Denmark	11	389 0.7×	68 0.4×	175 1.0×	39 0.2×	146 1.1×	19	674
Matthew T. Miller United States	16	868 1.6×	90 0.5×	473 2.6×	139 0.8×	128 0.9×	21	1.5k
Magda Marquet France	12	583 1.1×	309 1.6×	166 0.9×	49 0.3×	48 0.3×	16	875
Yoh‐ichi Matsumoto Japan	19	391 0.7×	137 0.7×	140 0.8×	30 0.2×	112 0.8×	25	786
Kazi Islam United States	11	476 0.9×	38 0.2×	281 1.6×	87 0.5×	63 0.5×	28	890

Countries citing papers authored by Mark S. Drinker

Since Specialization

Citations

This map shows the geographic impact of Mark S. Drinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Drinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Drinker more than expected).

Fields of papers citing papers by Mark S. Drinker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Drinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Drinker. The network helps show where Mark S. Drinker may publish in the future.

Co-authorship network of co-authors of Mark S. Drinker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Drinker. A scholar is included among the top collaborators of Mark S. Drinker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Drinker. Mark S. Drinker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ferrari, Guido, Justin Pollara, Daniel M. Kozink, et al.. (2011). An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum. Journal of Virology. 85(14). 7029–7036. 165 indexed citations

2.

Lin, Shih‐Wen, Scott E. Hensley, Marcio O. Lasaro, et al.. (2009). Effect of Preexisting Immunity on an Adenovirus Vaccine Vector: In Vitro Neutralization Assays Fail To Predict Inhibition by Antiviral Antibody In Vivo. Journal of Virology. 83(11). 5567–5573. 51 indexed citations

3.

Weeks, S.D., Mark S. Drinker, & Patrick J. Loll. (2006). Ligation independent cloning vectors for expression of SUMO fusions. Protein Expression and Purification. 53(1). 40–50. 116 indexed citations

4.

Drinker, Mark S., Xiangyang Zhou, Feng Xue, et al.. (2006). Structure-Based Identification of a Major Neutralizing Site in an Adenovirus Hexon. Journal of Virology. 81(4). 1680–1689. 89 indexed citations

5.

Malakhov, Michael P., Michael R. Mattern, Oxana A. Malakhova, et al.. (2004). SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. Journal of Structural and Functional Genomics. 5(1-2). 75–86. 426 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact